详情
Manufacturer
Fresenius Kabi Polska Sp. z.o.o.(POLAND)
Registraction Number
MAL20026060AZ
Here’s the information about Moxifloxacin Kabi 400mg/250ml Solution for Infusion (KabiPac):
Content
Active Ingredient: Moxifloxacin hydrochloride (400 mg per 250 mL), a fluoroquinolone antibiotic.
Excipients: Includes sodium acetate trihydrate and sulfuric acid.
Indication
Used for the treatment of:
Community-acquired pneumonia (CAP).
Complicated skin and skin structure infections (cSSSI).
Acute exacerbations of chronic bronchitis.
Instruction
Dosage:
The recommended dose is 400 mg once daily, infused over 60 minutes.
Duration of treatment varies based on the infection type (e.g., 7–14 days for CAP).
Administration:
Administered intravenously by a healthcare professional.
Initial IV treatment may be followed by oral therapy with moxifloxacin tablets.
Precautions:
Avoid use in patients with hypersensitivity to moxifloxacin or other quinolones.
Not recommended for children, pregnant women, or breastfeeding mothers.
Monitor for potential side effects such as nausea, dizziness, or tendonitis.
Use with caution in patients with liver impairment or a history of seizures.
更多 Complete Wellness 相关资料
Malaysia
